Total Assets (Quarterly) Chart

View Total Assets (Quarterly) for RVV.CX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Assets (Quarterly) Chart
Start Trial

Historical Total Assets (Quarterly) Data

View and export this data back to 2013. Start Trial.
Date Value
March 31, 2026 0.2818M
December 31, 2025 0.2614M
September 30, 2025 0.2498M
June 30, 2025 0.205M
March 31, 2025 9.628M
December 31, 2024 9.716M
September 30, 2024 10.05M
June 30, 2024 10.64M
March 31, 2024 13.14M
December 31, 2023 12.88M
September 30, 2023 13.78M
June 30, 2023 14.25M
March 31, 2023 15.77M
December 31, 2022 13.85M
September 30, 2022 14.76M
June 30, 2022 17.07M
March 31, 2022 18.43M
December 31, 2021 22.47M
September 30, 2021 28.06M
June 30, 2021 29.81M
March 31, 2021 32.35M
December 31, 2020 10.75M
September 30, 2020 10.08M
June 30, 2020 8.261M
March 31, 2020 7.388M
Date Value
December 31, 2019 1.256M
September 30, 2019 1.542M
June 30, 2019 1.283M
March 31, 2019 1.642M
December 31, 2018 0.5569M
September 30, 2018 0.8237M
June 30, 2018 1.120M
March 31, 2018 1.461M
December 31, 2017 1.560M
September 30, 2017 1.560M
June 30, 2017 1.924M
March 31, 2017 2.309M
December 31, 2016 1.811M
September 30, 2016 2.233M
June 30, 2016 1.387M
March 31, 2016 0.9008M
December 31, 2015 1.168M
September 30, 2015 1.943M
June 30, 2015 2.666M
March 31, 2015 3.102M
December 31, 2014 3.430M
September 30, 2014 1.170M
June 30, 2014 1.343M
March 31, 2014 1.648M
December 31, 2013 1.947M

Total Assets Definition

Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.

Read full definition.

Total Assets (Quarterly) Range, Past 5 Years

View Total Assets (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Assets (Quarterly) Benchmarks

View Total Assets (Quarterly) Benchmarks
Start Trial
HLS Therapeutics, Inc. 182.38M
Bausch Health Cos., Inc. 35.18B
Cipher Pharmaceuticals, Inc. 222.59M
BioSyent, Inc. 60.46M
Knight Therapeutics, Inc. 1.045B

Total Assets (Quarterly) Related Metrics